1-(2',3'-O-ISOPROPYLIDINE-5'-O-(TERT.-BUTYL-DIMETHYLSILYL)-BETA-D-RIBOFURANOSYL)-5,6-DIHYDRO-QUINAZOLINE-2,4-DIONE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 6d0WryBjuDV |
|---|---|
| InChI | InChI=1S/C22H34N2O6Si/c1-21(2,3)31(6,7)27-12-15-16-17(30-22(4,5)29-16)19(28-15)24-14-11-9-8-10-13(14)18(25)23-20(24)26/h9,11,15-17,19H,8,10,12H2,1-7H3,(H,23,25,26)/t15-,16-,17-,19-/m1/s1 |
| InChIKey | HSULLLDPHDDIGF-YWTNHNAXSA-N |
| Mol Weight | 450.6 g/mol |
| Molecular Formula | C22H34N2O6Si |
| Exact Mass | 450.218613 g/mol |
| Enantiomer InChIKey | HSULLLDPHDDIGF-DWRORGKVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | Unknown |
1-(2',3'-O-ISOPROPYLIDINE-5'-O-(TERT.-BUTYL-DIMETHYLSILYL)-BETA-D-RIBOFURANOSYL)-7,8-DIHYDRO-QUINAZOLINE-2,4-DIONE
(1S,3R,5R,6R,8R)-5-BENZYLOXY-6-BENZYLOXYMETHYL-3-(TERT.-BUTYLDIMETHYLSILYLOXYMETHYL)-8-(THYMIN-1-YL)-2,7-DIOXA-BICYCLO-[3.3.0]-OCTANE
(1S,3S,5R,6R,8R)-5-BENZYLOXY-6-BENZYLOXYMETHYL-3-(TERT.-BUTYLDIMETHYLSILYLOXYMETHYL)-8-(THYMIN-1-YL)-2,7-DIOXA-BICYCLO-[3.3.0]-OCTANE
CYGAGQMORSPERG-VWMGYNLJSA-N
CEWNGWIAOJUILI-BMERVDLTSA-N
5'-O-DIMETHOXYTRITYL-3'-O-TERT.-BUTYLDIPHENYLSILYL-ALPHA,BETA-D-CNA-TT-(RC,RP)
1-(2,3-O-ISOPROPYLIDENE-5-O-METHANESULFONYL-BETA-D-RIBOFURANOSYL)-THIENO-[3.2-D]-PYRIMIDINE-2,4-DIONE
LAUREN-1-EN-14-ONE
Apigenin 7-O-neohesperidoside, octa-TMS
(1S,3R,5R,6R,8R)-3-ACETOXYMETHYL-5-BENZYLOXY-6-BENZYLOXYMETHYL-8-(THYMIN-1-YL)-2,7-DIOXABICYCLO-[3.3.0]-OCTANE
| Title | Journal or Book | Year |
|---|---|---|
| A chemical model for the fragmentation reaction in thymidylate synthase catalysis. Synthesis and evaluation of a 5-methylene-1-(1,2,3,4-tetrahydroquinolyl)-6-allyluridine | The Journal of Organic Chemistry | 1993 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.